Definitive Healthcare Corp. (NASDAQ:DH) Receives Consensus Recommendation of “Hold” from Brokerages

Definitive Healthcare Corp. (NASDAQ:DHGet Free Report) has earned a consensus rating of “Hold” from the eleven brokerages that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $5.72.

Several analysts have recently weighed in on DH shares. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research report on Thursday, January 16th. Stephens assumed coverage on Definitive Healthcare in a research report on Friday, December 20th. They set an “equal weight” rating and a $5.00 price target on the stock. Finally, Barclays reiterated an “underweight” rating and issued a $4.00 price objective on shares of Definitive Healthcare in a report on Monday, January 13th.

View Our Latest Research Report on DH

Insider Buying and Selling

In related news, insider William Moschella sold 45,000 shares of the company’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total transaction of $211,500.00. Following the completion of the sale, the insider now directly owns 433,830 shares in the company, valued at $2,039,001. This represents a 9.40 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 14.84% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Definitive Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the company. Nisa Investment Advisors LLC raised its holdings in shares of Definitive Healthcare by 3,652.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company’s stock valued at $29,000 after acquiring an additional 6,794 shares in the last quarter. Bayesian Capital Management LP bought a new position in Definitive Healthcare in the 4th quarter worth $41,000. Point72 DIFC Ltd raised its holdings in Definitive Healthcare by 759.9% in the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock worth $42,000 after purchasing an additional 8,215 shares in the last quarter. Ieq Capital LLC purchased a new stake in shares of Definitive Healthcare in the 4th quarter worth about $51,000. Finally, KLP Kapitalforvaltning AS bought a new stake in shares of Definitive Healthcare during the 4th quarter valued at about $54,000. 98.67% of the stock is owned by institutional investors.

Definitive Healthcare Stock Down 5.2 %

DH stock opened at $4.92 on Monday. Definitive Healthcare has a 1-year low of $3.19 and a 1-year high of $10.62. The stock has a market cap of $568.36 million, a price-to-earnings ratio of -1.59, a price-to-earnings-growth ratio of 4.06 and a beta of 1.45. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. The company’s 50 day moving average is $4.60 and its 200 day moving average is $4.45.

About Definitive Healthcare

(Get Free Report

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

Featured Articles

Analyst Recommendations for Definitive Healthcare (NASDAQ:DH)

Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.